Table 3.
Clinical data about hypoalbuminemics and normoalbuminemics
| Hypoalbuminemics | Normoalbuminemics | p value | |
| (N=50) | (N=12) | ||
| Survivor/non-survivor | 10/40 | 5/7 | 0.142 |
| Age (years) | 63±16 | 62±19 | 0.064 |
| Albumin (g/L) | 1.8±0.4 | 3.0±0.4 | <0.001 |
| Baseline cortisol (µg/dL) | 23[15-32] | 22[15-332] | 0.866 |
| Baseline cortisol < 25 µ g/dL | 30(60) | 9 (75) | 0.508 |
| Baseline cortisol/albumin | 13.3 [7.3-18.4] | 7.8 [4.8-10.2] | 0.011 |
| Peak cortisol ( µ g/dL) | 40±21 | 36±12 | 0.538 |
| Cortisol increase ( µ g/dL) | 14±13 | 13±7 | 0.781 |
| Cortisol increase/albumin | 8.2±6.9 | 4.7±2.5 | 0.08 |
| Cortisol increase (%) | 0.57±0.21 | 0.63±0.32 | 0.964 |
| Admission APACHE II | 22.3±7.8 | 21.4±6.8 | 0.754 |
APACHE - Acute Physiology and Chronic Health Evaluation. Hypoalbuminemia; albuminemia level <2.5 mg/dL. Data are expressed as the mean±standard deviation, median [percentiles 25-75%] or number (%), where appropriate, by the indicated statistical test.